VSTM Reports $0 Revenue, $0 EPS, RAS/MAPK Therapy Pipeline, $150M Funding Risk, FDA Approval Uncertainty
Verastem, Inc. · PHARMACEUTICAL PREPARATIONS · Now $4.19
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS